Program Overview
Program covers recent advances in the diagnosis and management of glomerular disease in a one-day course.

Learning Objectives

• Identify Current Treatment Guidelines for Glomerular Diseases.
• Explore Targeted Therapies for C3G, IgA Nephropathy, and ANCA Vasculitis.
• Assess the Role of SGLT2 Inhibitors in Non-Diabetic Glomerular Diseases.
• Discuss Monitoring and Management of Treatment-related Adverse Events.
• Review Case Studies and Real-world Scenarios.

Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Columbia University. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Professions in scope for this activity are listed below. Amedco Joint Accreditation Provider Number: 4008163.

Physicians (ACCME) Credit Designation Statement
Amedco LLC designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credits™ for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit.

Physician Assistants
The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credit™ are acceptable for continuing medical education requirements for recertification for PAs.

Amedco LLC designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credits™. PAs should claim only the credit commensurate with the extent of their participation in the activity.